{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:50:34Z","timestamp":1790614234218,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier","isbn-type":[{"value":"9780128208168","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.vh.2019.08.012","type":"book-chapter","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T04:47:37Z","timestamp":1583124457000},"page":"79-99","source":"Crossref","is-referenced-by-count":23,"title":["V2 vasopressin receptor mutations"],"prefix":"10.1016","member":"78","reference":[{"issue":"10","key":"10.1016\/bs.vh.2019.08.012_bb0010","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.V9101861","article-title":"Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: Molecular basis of a mild clinical phenotype","volume":"9","author":"Ala","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41467-018-03771-2","article-title":"AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus","volume":"9","author":"Ando","year":"2018","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/bs.vh.2019.08.012_bb0020","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1681\/ASN.V1161044","article-title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus","volume":"11","author":"Arthus","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cell.2012.09.003","article-title":"Restructuring G-protein-coupled receptor activation","volume":"151","author":"Audet","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.98.1.93","article-title":"Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus","volume":"98","author":"Barak","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/bs.vh.2019.08.012_bb0040","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI116698","article-title":"X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis","volume":"92","author":"Bichet","year":"1993","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0045","first-page":"278","article-title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus","volume":"55","author":"Bichet","year":"1994","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.beem.2016.02.010","article-title":"Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)","volume":"30","author":"Bichet","year":"2016","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"issue":"7","key":"10.1016\/bs.vh.2019.08.012_bb0055","first-page":"886","article-title":"An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs\/adenylyl cyclase system","volume":"8","author":"Birnbaumer","year":"1994","journal-title":"Molecular Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2019.08.012_bb0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nature Reviews. Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000245059","article-title":"Vasopressin type 2 receptor V88M mutation: Molecular basis of partial and complete nephrogenic diabetes insipidus","volume":"114","author":"Bockenhauer","year":"2009","journal-title":"Nephron. Physiology"},{"issue":"3","key":"10.1016\/bs.vh.2019.08.012_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.semnephrol.2008.03.010","article-title":"Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus","volume":"28","author":"Bouley","year":"2008","journal-title":"Seminars in Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1681\/ASN.2009121267","article-title":"Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration","volume":"22","author":"Bouley","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1016\/bs.vh.2019.08.012_bb0080","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1681\/ASN.2012010077","article-title":"Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD","volume":"23","author":"Carpentier","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s100380200002","article-title":"Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients","volume":"47","author":"Chen","year":"2002","journal-title":"Journal of Human Genetics"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0090","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2006090987","article-title":"Nephrogenic syndrome of inappropriate antidiuresis in adults: High phenotypic variability in men and women from a large pedigree","volume":"18","author":"Decaux","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1016\/bs.vh.2019.08.012_bb0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00041552-200011000-00001","article-title":"Nephrogenic diabetes insipidus","volume":"9","author":"Deen","year":"2000","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"5","key":"10.1016\/bs.vh.2019.08.012_bb0100","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2015.181","article-title":"Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis","volume":"88","author":"Erdelyi","year":"2015","journal-title":"Kidney International"},{"issue":"3","key":"10.1016\/bs.vh.2019.08.012_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2265.2007.03054.x","article-title":"Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene","volume":"68","author":"Faerch","year":"2008","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2019.08.012_bb0110","doi-asserted-by":"crossref","first-page":"F1518","DOI":"10.1152\/ajprenal.00331.2009","article-title":"Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus","volume":"297","author":"Faerch","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"18","key":"10.1016\/bs.vh.2019.08.012_bb0115","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis","volume":"352","author":"Feldman","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2019.08.012_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.med.46.1.331","article-title":"Molecular biology of diabetes insipidus","volume":"46","author":"Fujiwara","year":"1995","journal-title":"Annual Review of Medicine"},{"issue":"27","key":"10.1016\/bs.vh.2019.08.012_bb0125","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1073\/pnas.1509565112","article-title":"Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts","volume":"112","author":"Gao","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.vh.2019.08.012_bb0130","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.272.5.2587","article-title":"Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility","volume":"272","author":"Gether","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2019.08.012_bb0135","doi-asserted-by":"crossref","DOI":"10.1530\/EDM-17-0139","article-title":"Adult female with symptomatic AVPR2-related nephrogenic syndrome of inappropriate antidiuresis (NSIAD)","volume":"2018","author":"Hague","year":"2018","journal-title":"Endocrinology, Diabetes & Metabolism Case Reports"},{"issue":"28","key":"10.1016\/bs.vh.2019.08.012_bb0140","doi-asserted-by":"crossref","first-page":"16602","DOI":"10.1074\/jbc.270.28.16602","article-title":"A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type 1 angiotensin II receptor","volume":"270","author":"Hunyady","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"issue":"6493","key":"10.1016\/bs.vh.2019.08.012_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/371164a0","article-title":"Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function","volume":"371","author":"Iiri","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/jcem.86.1.7165","article-title":"The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus","volume":"86","author":"Inaba","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/bs.vh.2019.08.012_bb0155","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1681\/ASN.2008121289","article-title":"Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus","volume":"20","author":"Jean-Alphonse","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1016\/bs.vh.2019.08.012_bb0160","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/mol.107.040352","article-title":"Functional selectivity through protean and biased agonism: Who steers the ship?","volume":"72","author":"Kenakin","year":"2007","journal-title":"Molecular Pharmacology"},{"issue":"4","key":"10.1016\/bs.vh.2019.08.012_bb0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/me.2008-0321","article-title":"Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis","volume":"23","author":"Kocan","year":"2009","journal-title":"Molecular Endocrinology"},{"issue":"11","key":"10.1016\/bs.vh.2019.08.012_bb0170","doi-asserted-by":"crossref","first-page":"F1395","DOI":"10.1152\/ajprenal.00376.2011","article-title":"In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac","volume":"302","author":"Kortenoeven","year":"2012","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"41","key":"10.1016\/bs.vh.2019.08.012_bb0175","doi-asserted-by":"crossref","first-page":"37944","DOI":"10.1074\/jbc.M106330200","article-title":"Interaction of Met297 in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A","volume":"276","author":"Labrou","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/bs.vh.2019.08.012_bb0180","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1172\/JCI39680","article-title":"A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus","volume":"119","author":"Li","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0185","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00001.2011","article-title":"Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase","volume":"301","author":"Li","year":"2011","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"6376","key":"10.1016\/bs.vh.2019.08.012_bb0190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/357336a0","article-title":"Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus","volume":"357","author":"Lolait","year":"1992","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCRESAHA.112.277665","article-title":"Attenuated desensitization of beta-adrenergic receptor by water-soluble N-nitrosamines that induce S-nitrosylation without NO release","volume":"112","author":"Makita","year":"2013","journal-title":"Circulation Research"},{"issue":"13","key":"10.1016\/bs.vh.2019.08.012_bb0200","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1073\/pnas.0701290104","article-title":"An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations","volume":"104","author":"Makita","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"43","key":"10.1016\/bs.vh.2019.08.012_bb0205","doi-asserted-by":"crossref","first-page":"22460","DOI":"10.1074\/jbc.M116.733220","article-title":"Analysis of the V2 vasopressin receptor (V2R) mutations causing partial nephrogenic diabetes insipidus highlights a sustainable signaling by a non-peptide V2R agonist","volume":"291","author":"Makita","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/bs.vh.2019.08.012_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112385","article-title":"Hereditary nephrogenic diabetes insipidus: Pathophysiology and possible treatment. An update","volume":"18","author":"Milano","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2012-1044","article-title":"Nephrogenic diabetes insipidus: Essential insights into the molecular background and potential therapies for treatment","volume":"34","author":"Moeller","year":"2013","journal-title":"Endocrine Reviews"},{"issue":"7","key":"10.1016\/bs.vh.2019.08.012_bb0220","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.metabol.2012.01.005","article-title":"Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: A case report and review of the literature","volume":"61","author":"Neocleous","year":"2012","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/bs.vh.2019.08.012_bb0225","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1210\/jcem.82.10.4312","article-title":"Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation","volume":"82","author":"Nomura","year":"1997","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"31","key":"10.1016\/bs.vh.2019.08.012_bb0230","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1073\/pnas.1104691108","article-title":"Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus","volume":"108","author":"Olesen","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng1092-103","article-title":"Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus","volume":"2","author":"Pan","year":"1992","journal-title":"Nature Genetics"},{"issue":"50","key":"10.1016\/bs.vh.2019.08.012_bb0240","doi-asserted-by":"crossref","first-page":"31933","DOI":"10.1016\/S0021-9258(18)31785-X","article-title":"The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin","volume":"269","author":"Pan","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.vh.2019.08.012_bb0245","first-page":"1703","article-title":"Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families","volume":"85","author":"Pasel","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0250","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cen.13011","article-title":"Nephrogenic syndrome of inappropriate antidiuresis secondary to an activating mutation in the arginine vasopressin receptor AVPR2","volume":"85","author":"Powlson","year":"2016","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.2014.10","article-title":"Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice","volume":"86","author":"Procino","year":"2014","journal-title":"Kidney International"},{"issue":"5","key":"10.1016\/bs.vh.2019.08.012_bb0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM199801293380611","article-title":"X inactivation in females with X-linked disease","volume":"338","author":"Puck","year":"1998","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0265","doi-asserted-by":"crossref","first-page":"F265","DOI":"10.1152\/ajprenal.00404.2004","article-title":"Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model","volume":"289","author":"Robben","year":"2005","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"29","key":"10.1016\/bs.vh.2019.08.012_bb0270","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1073\/pnas.0900130106","article-title":"Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by non-peptide agonists","volume":"106","author":"Robben","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0275","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00247.2006","article-title":"Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: Relevance to therapy of nephrogenic diabetes insipidus","volume":"292","author":"Robben","year":"2007","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"5","key":"10.1016\/bs.vh.2019.08.012_bb0280","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.109.061804","article-title":"Functional characterization of vasopressin type 2 receptor substitutions (R137H\/C\/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: Implications for treatments","volume":"77","author":"Rochdi","year":"2010","journal-title":"Molecular Pharmacology"},{"issue":"18","key":"10.1016\/bs.vh.2019.08.012_bb0285","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1016\/S0021-9258(19)38614-4","article-title":"Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase","volume":"268","author":"Rosenthal","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"issue":"6392","key":"10.1016\/bs.vh.2019.08.012_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/359233a0","article-title":"Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus","volume":"359","author":"Rosenthal","year":"1992","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.vh.2019.08.012_bb0295","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/mend.11.12.0017","article-title":"Biochemical basis of partial nephrogenic diabetes insipidus phenotypes","volume":"11","author":"Sadeghi","year":"1997","journal-title":"Molecular Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2019.08.012_bb0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000308167","article-title":"Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families","volume":"73","author":"Sahakitrungruang","year":"2010","journal-title":"Hormone Research in P\u00e6diatrics"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1507\/endocrj.K07-083","article-title":"Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations","volume":"55","author":"Satoh","year":"2008","journal-title":"Endocrine Journal"},{"issue":"Pt. 1","key":"10.1016\/bs.vh.2019.08.012_bb0310","first-page":"1","article-title":"In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors","volume":"283","author":"Savarese","year":"1992","journal-title":"The Biochemical Journal"},{"issue":"4","key":"10.1016\/bs.vh.2019.08.012_bb0315","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1074\/jbc.275.4.2381","article-title":"Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors","volume":"275","author":"Schulz","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.vh.2019.08.012_bb0320","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcp.21552","article-title":"AVPR2 variants and mutations in nephrogenic diabetes insipidus: Review and missense mutation significance","volume":"217","author":"Spanakis","year":"2008","journal-title":"Journal of Cellular Physiology"},{"issue":"3","key":"10.1016\/bs.vh.2019.08.012_bb0325","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1074\/jbc.M111.268797","article-title":"V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists","volume":"287","author":"Takahashi","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0330","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ki.1995.327","article-title":"Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus","volume":"48","author":"Tsukaguchi","year":"1995","journal-title":"Kidney International"},{"issue":"2","key":"10.1016\/bs.vh.2019.08.012_bb0335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ng1092-99","article-title":"Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus","volume":"2","author":"van den Ouweland","year":"1992","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/bs.vh.2019.08.012_bb0340","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/j.1460-2075.1993.tb05661.x","article-title":"Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor","volume":"12","author":"Wess","year":"1993","journal-title":"The EMBO Journal"},{"issue":"6","key":"10.1016\/bs.vh.2019.08.012_bb0345","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1046\/j.1523-1755.1998.00214.x","article-title":"AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus","volume":"54","author":"Wildin","year":"1998","journal-title":"Kidney International"},{"issue":"4","key":"10.1016\/bs.vh.2019.08.012_bb0350","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00411.2005","article-title":"Epac-mediated Ca(2+) mobilization and exocytosis in inner medullary collecting duct","volume":"291","author":"Yip","year":"2006","journal-title":"American Journal of Physiology. Renal Physiology"}],"container-title":["Vitamins and Hormones","Vasopressin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008367291930072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008367291930072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:39:24Z","timestamp":1758760764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008367291930072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128208168"],"references-count":69,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2019.08.012","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}